Internal Medicine, Hematology & Oncology · Palm Springs, FL
NPI
1497933998
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1630 S Congress Ave Ste 200
Palm Springs, FL, 33461
Phone (561) 253-3980
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
98,947 services
Medicare patients, 2024
813
Average age 78
Drug cost, 2024
$4.8M
1,513 prescriptions
Company payments, 2025
$72.77
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raymond E Tsao was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 20,400 times for 30 patients. In total Raymond E Tsao billed 98,947 services in 107 codes, and Medicare paid $1.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 20,400 | 30 | $0.27 | $5,509 |
| J0897 Injection, denosumab, 1 mg | Office | 3,240 | 19 | $20.46 | $66K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,960 | 13 | $6.32 | $12K |
| 85025 Blood Count | Office | 1,619 | 591 | $7.56 | $12K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,406 | 37 | $0.09 | $126 |
| 99214 Office E&M - Established | Office | 1,312 | 437 | $96.77 | $127K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 800 | 27 | $0.71 | $569 |
| J9190 Injection, fluorouracil, 500 mg | Office | 375 | 12 | $2.23 | $835 |
| 99215 Office E&M - Established | Office | 331 | 198 | $136.24 | $45K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 329 | 12 | $3.53 | $1,161 |
| 36415 Venipuncture Blood Collection | Office | 327 | 230 | $8.65 | $2,829 |
| 96413 Chemotherapy Administration | Office | 215 | 63 | $101.80 | $22K |
| 96367 Intravenous Infusion, Hydration | Office | 196 | 46 | $22.30 | $4,370 |
| 96372 Injection Administration | Office | 170 | 66 | $11.25 | $1,912 |
| 96375 Injection Administration | Office | 161 | 36 | $12.17 | $1,959 |
By year: 2022 $1.9M for 99,416 services; 2023 $1.7M for 77,599 services; 2024 $1.7M for 98,947 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,619 | 591 | $7.56 | $12K |
| 36415 Venipuncture Blood Collection | 327 | 230 | $8.65 | $2,829 |
Medicare prescription drug claims, 2024
In 2024, the drug Raymond E Tsao prescribed most often to Medicare patients was Eliquis (Apixaban), with 235 prescriptions and refills. In total Raymond E Tsao wrote 1,513 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 235 | 345 | 46 | $196K |
| Xarelto Rivaroxaban | 92 | 163 | 22 | $89K |
| Hydroxyurea Generic | 81 | 164 | 20 | $2,213 |
| Acyclovir Generic | 76 | 112 | 15 | $873 |
| Imatinib Mesylate Generic | 66 | 68 | Under 11 | $9,593 |
| Dexamethasone Generic | 60 | 66 | 16 | $1,001 |
| Lenalidomide Generic | 58 | 58 | Under 11 | $858K |
| Revlimid Lenalidomide | 33 | 33 | Under 11 | $612K |
| Oxycodone Hcl Generic | 32 | 32 | 11 | $766 |
| Prednisone Generic | 31 | 31 | 16 | $94.47 |
| Tramadol Hcl Generic | 28 | 28 | Under 11 | $136 |
| Gabapentin Generic | 28 | 28 | Under 11 | $184 |
| Fentanyl Generic | 27 | 27 | Under 11 | $2,446 |
| Imbruvica Ibrutinib | 26 | 26 | Under 11 | $206K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 23 | 23 | Under 11 | $398 |
Brand drugs: - claims; generic drugs: 890 claims; opioid claims: 131.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raymond E Tsao $72.77 ($72.77 in general payments such as food, travel and fees) from 3 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $35.06.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.